Journal
CELL REPORTS
Volume 16, Issue 3, Pages 605-614Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2016.06.018
Keywords
-
Categories
Funding
- NIH [R01NS088627, R21DE025689, T32ES007148]
- New Jersey Commission on Spinal Cord Research [CSCR15ERG015, CSCR13IRG006]
- National Natural Science Foundation of China [81200857, 81571351, 81371510]
Ask authors/readers for more resources
Peripheral nerve injury causes neuropathic pain accompanied by remarkable microgliosis in the spinal cord dorsal horn. However, it is still debated whether infiltrated monocytes contribute to injury-induced expansion of the microglial population. Here, we found that spinal microgliosis predominantly results from local proliferation of resident microglia but not from infiltrating monocytes after spinal nerve transection (SNT) by using two genetic mouse models (CCR2(RFP/+):CX3CR1(GFP/+) and CX3CR1(creER/+):R26(tdTomato/+) mice) as well as specific staining of microglia and macrophages. Pharmacological inhibition of SNT-induced microglial proliferation correlated with attenuated neuropathic pain hypersensitivities. Microglial proliferation is partially controlled by purinergic and fractalkine signaling, as CX3CR1(-/-) and P2Y12(-/-) mice show reduced spinal microglial proliferation and neuropathic pain. These results suggest that local microglial proliferation is the sole source of spinal microgliosis, which represents a potential therapeutic target for neuropathic pain management.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available